{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:22:51Z","timestamp":1784809371071,"version":"3.55.0"},"reference-count":34,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81172199"],"award-info":[{"award-number":["81172199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472744"],"award-info":[{"award-number":["81472744"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773178"],"award-info":[{"award-number":["81773178"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CGT"],"published-print":{"date-parts":[[2019,5,28]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Both Drosophila melanogaster deoxyribonucleoside kinase (Dm-dNK) suicide gene therapy and exogenous CD40 ligand (CD40L)-CD40 interaction in cancer via conditionally replicating adenovirus can selectively kill tumors without damaging normal tissues.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>To further improve the cancer killing effect, we investigated the therapeutic effect of combined cancer gene therapy based on a selective oncolytic adenovirus vector containing Dm-dNK suicide gene and exogenous CD40L on breast carcinoma cells in vitro and in vivo.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>A series of conditionally replicating adenoviruses using adenovirus vector P74 were generated: P74-dNK, P74-CD40L (expressing Dm-dNK or CD40L respectively), and P74-dNK-CD40L (expressing combined Dm-dNK and CD40L). Breast cancer cell lines (MDA-MB-231, MCF-7) and non-tumor cell line (MRC5) were treated with adenovirus and cytotoxicity determined by MTT assay, and apoptosis assessed by flow cytometry after 72h. We also assessed in vivo cell killing efficiency using a mouse xenograft model with MDA-MB-231 cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and Discussion:<\/jats:title><jats:p>Co-expression of Dm-dNK and CD40L reduced cell proliferation of MDAMB- 231 or MCF7 cancer cells, and induced more apoptosis in TERT and CD40 positive cancer cells, but not normal MRC5 cells. Significant reduction in tumor volume was also seen in combined treatment arms as compared to any single treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Our data suggest enhanced, selective tumor cell killing using combined gene therapy with conditionally replicating adenovirus containing Dm-dNK suicide gene and exogenous CD40 ligation (CD40L-CD40).<\/jats:p><\/jats:sec>","DOI":"10.2174\/1566523219666190307094713","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T11:33:12Z","timestamp":1552044792000},"page":"54-65","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Novel Combination Oncolytic Adenoviral Gene Therapy Armed with Dm-dNK and CD40L for Breast Cancer"],"prefix":"10.2174","volume":"19","author":[{"given":"Qiuli","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muwen","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[{"name":"Lab 1, Cancer Institute, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhong","sequence":"additional","affiliation":[{"name":"Hebei University College of Life Sciences, Baoding, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3322\/caac.21412","volume":"67","author":"DeSantis C.E.","year":"2017","unstructured":"DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state.","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2012.09.003","volume":"328","author":"Dong X.","year":"2013","unstructured":"Dong X, Qu W, Ma S. Potent antitumoral effects of targeted promoter-driven oncolytic adenovirus armed with Dm-dNK for breast cancer and","journal-title":"Cancer Lett"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"102617","DOI":"10.18632\/oncotarget.18309","volume":"8","author":"Fountzilas C.","year":"2017","unstructured":"Fountzilas C, Patel S, Mahalingam D. Review: Oncolytic virotherapy, updates and future directions.","journal-title":"Oncotarget"},{"key":"ref=4","first-page":"3301","volume":"9","author":"Tang M.","year":"2015","unstructured":"Tang M, Zu C, He A, Wang W, Chen B, Zheng X. Synergistic antitumor effect of adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase and nucleoside analogs for human breast carcinoma and","journal-title":"Drug Des Devel Ther"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.1021\/cr5002035","volume":"114","author":"Pradere U.","year":"2014","unstructured":"Pradere U, Garnier-Amblard EC, Coats SJ, Amblard F, Schinazi RF. Synthesis of nucleoside phosphate and phosphonate prodrugs.","journal-title":"Chem Rev"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.antiviral.2005.05.001","volume":"67","author":"De Clercq E.","year":"2005","unstructured":"De Clercq E. Antiviral drug discovery and development: Where chemistry meets with biomedicine.","journal-title":"Antiviral Res"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2249.2007.03426.x","volume":"149","author":"Toutirais O.","year":"2007","unstructured":"Toutirais O, Gervais A, Cabillic F. Effects of CD40 binding on ovarian carcinoma cell growth and cytokine production","journal-title":"Clin Exp Immunol"},{"key":"ref=8","first-page":"2","volume":"29","author":"Bereznaya N.M.","year":"2007","unstructured":"Bereznaya NM, Chekhun VF. Expression of CD40 and CD40L on tumor cells: The role of their interaction and new approach to immunotherapy.","journal-title":"Exp Oncol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(09)60404-9","volume":"373","author":"Disis M.L.","year":"2009","unstructured":"Disis ML, Bernhard H, Jaffee EM. Use of tumour-responsive T cells as cancer treatment.","journal-title":"Lancet"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1126\/science.1072615","volume":"297","author":"Bourgeois C.","year":"2002","unstructured":"Bourgeois C, Rocha B, Tanchot C. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.","journal-title":"Science"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.5301\/tj.5000297","volume":"101","author":"Parameswaran S.","year":"2015","unstructured":"Parameswaran S, Khalil M, Ahmed KA, Sharma RK, Xiang J. Enhanced protective immunity derived from dendritic cells with phagocytosis of CD40 ligand transgene-engineered apoptotic tumor cells increased dendritic cell maturation.","journal-title":"Tumori"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/eji.201545554","volume":"46","author":"Trella E.","year":"2016","unstructured":"Trella E, Raafat N, Mengus C. CD40 ligand-expressing recombinant vaccinia virus promotes the generation of CD8(+) central memory T cells.","journal-title":"Eur J Immunol"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00262-016-1847-0","volume":"65","author":"Zhou Y.","year":"2016","unstructured":"Zhou Y, Zhou SX, Gao L, Li XA. Regulation of CD40 signaling in colon cancer cells and its implications in clinical tissues.","journal-title":"Cancer Immunol Immunother"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1158\/1078-0432.CCR-08-1360","volume":"15","author":"Gomes E.M.","year":"2009","unstructured":"Gomes EM, Rodrigues MS, Phadke AP. Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells.","journal-title":"Clin Cancer Res"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/bjc.2016.42","volume":"114","author":"Loskog A.","year":"2016","unstructured":"Loskog A, Maleka A, Mangsbo S. Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophos- phamide in metastatic melanoma patients.","journal-title":"Br J Cancer"},{"key":"ref=16","first-page":"1443","volume":"27","author":"Ma S.","year":"2012","unstructured":"Ma S, Qu W, Mao L. Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer.","journal-title":"Oncol Rep"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1128\/JVI.70.10.7030-7038.1996","volume":"70","author":"Zhou H.","year":"1996","unstructured":"Zhou H, O\u2019Neal W, Morral N, Beaud AL. Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted.","journal-title":"J Virol"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"874","DOI":"10.4161\/cbt.11.10.15182","volume":"11","author":"Zhu Z.","year":"2011","unstructured":"Zhu Z, Mao L, Zhao L. Synergistic therapeutic effect in gastric cancer cells produced by oncolytic adenovirus encoding Drosophila melanogaster deoxyribonucleoside kinase.","journal-title":"Cancer Biol Ther"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"9447","DOI":"10.1007\/s13277-014-2407-x","volume":"35","author":"Korniluk A.","year":"2014","unstructured":"Korniluk A, Kemona H, Dymicka-Piekarska V. Multifunctional CD40L: Pro- and anti-neoplastic activity.","journal-title":"Tumour Biol"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood.V99.4.1419","volume":"99","author":"Tai Y.T.","year":"2002","unstructured":"Tai YT, Podar K, Gupta D. CD40 activation induces p53-dependent vascular endothelial growth factor secretion in human multiple myeloma cells.","journal-title":"Blood"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood-2002-09-2813","volume":"101","author":"Tai Y.T.","year":"2003","unstructured":"Tai YT, Podar K, Mitsiades N. CD40 induces human multiple myeloma cell migration phosphatidylinositol 3-kinase\/ AKT\/NF-kappa B signaling.","journal-title":"Blood"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1007\/s11033-011-0702-9","volume":"38","author":"Li R.","year":"2011","unstructured":"Li R, Chen WC, Pang XQ, Tian WY, Zhang XG. Influence of sCD40L on gastric cancer cell lines.","journal-title":"Mol Biol Rep"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00262-011-1194-0","volume":"61","author":"Zhou Y.","year":"2012","unstructured":"Zhou Y, He J, Gou LT. Expression of CD40 and growth-inhibitory activity of CD40 agonist in ovarian carcinoma cells.","journal-title":"Cancer Immunol Immunother"},{"key":"ref=24","first-page":"262","volume":"28","author":"He S.","year":"2012","unstructured":"He S, Zhao H, Fei M. Expression of the co-signaling molecules CD40-CD40L and their growth inhibitory effect on pancreatic cancer","journal-title":"Oncol Rep"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.3390\/v7112905","volume":"7","author":"Cheng P.H.","year":"2015","unstructured":"Cheng PH, Wechman SL, McMasters KM, Zhou HS. Oncolytic Replication of E1b-Deleted Adenoviruses.","journal-title":"Viruses"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.cgt.7700739","volume":"11","author":"Rao X.M.","year":"2004","unstructured":"Rao XM, Tseng MT, Zheng X. E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells.","journal-title":"Cancer Gene Ther"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.4049\/jimmunol.178.4.2047","volume":"178","author":"Murugaiyan G.","year":"2007","unstructured":"Murugaiyan G, Agrawal R, Mishra GC. Differential CD40\/CD40L expression results in counteracting antitumor immune responses.","journal-title":"J Immunol"},{"key":"ref=28","author":"Eriksson E.","year":"2016","unstructured":"Eriksson E, Moreno R, Milenova I. Activation of myeloid- and endothelial cells by CD40L gene therapy supports T cell expansion and migration into the tumor microenvironment.","journal-title":"Gene Ther"},{"key":"ref=29","first-page":"7556","volume":"61","author":"Ghamande S.","year":"2001","unstructured":"Ghamande S, Hylander BL, Oflazoglu E. Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin.","journal-title":"Cancer Res"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3892\/mco.2015.519","volume":"3","author":"Kubo M.","year":"2015","unstructured":"Kubo M, Satoh T, Tabata KI. Enhanced central memory cluster of differentiation 8+ and tumor antigen-specific T cells in prostate cancer patients receiving repeated adenovirus-mediated suicide gene therapy.","journal-title":"Mol Clin Oncol"},{"key":"ref=31","first-page":"3529","volume":"58","author":"Wei M.X.","year":"1998","unstructured":"Wei MX, Bougnoux P, Sacre-Salem B. Suicide gene therapy of chemically induced mammary tumor in rat: Efficacy and distant bystander effect.","journal-title":"Cancer Res"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1084\/jem.20171093","volume":"214","author":"Zhu Z.","year":"2017","unstructured":"Zhu Z, Gorman MJ, McKenzie LD. Zika virus has oncolytic activity against glioblastoma stem cells.","journal-title":"J Exp Med"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/156652308784049372","volume":"8","author":"Ribacka C.","year":"2008","unstructured":"Ribacka C, Hemminki A. Virotherapy as an approach against cancer stem cells.","journal-title":"Curr Gene Ther"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7150\/jca.16406","volume":"8","author":"Lv S.Q.","year":"2017","unstructured":"Lv SQ, Ye ZL, Liu PY. 11R-P53 and GM-CSF expressing oncolytic adenovirus target cancer stem cells with enhanced synergistic activity.","journal-title":"J Cancer"}],"container-title":["Current Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T18:01:49Z","timestamp":1606672909000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170518\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5,28]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566523219666190307094713","relation":{},"ISSN":["1566-5232"],"issn-type":[{"value":"1566-5232","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}